Putnam BioRevolution ETF is a ETF series of Putnam ETF Trust (series S000077138). Net assets $4.7M as of 2025-10-31.
Showing 15 of 33 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Thermo Fisher Scientific Inc | — | $428K | 918.36% |
| AbbVie Inc | — | $251K | 537.08% |
| NVIDIA Corp | — | $240K | 513.97% |
| Corteva Inc | — | $228K | 489.06% |
| Bio-Rad Laboratories Inc | — | $223K | 477.48% |
| Putnam Government Money Market Fund | — | $222K | 476.47% |
| Ascendis Pharma A/S | — | $219K | 469.36% |
| Novonesis Novozymes B | — | $212K | 454.07% |
| AstraZeneca PLC | — | $208K | 445.69% |
| Eli Lilly & Co | — | $184K | 394.01% |
| Cadence Design Systems Inc | — | $176K | 377.56% |
| DuPont de Nemours Inc | — | $167K | 357.43% |
| Regeneron Pharmaceuticals Inc | — | $160K | 342.35% |
| ICON PLC | — | $155K | 331.51% |
| Danaher Corp | — | $149K | 319.06% |
| Report date | Net assets |
|---|---|
| 2025-10-31 | $4.7M |
| 2025-07-31 | $5.1M |
| 2025-04-30 | $4.8M |
| 2025-01-31 | $5.4M |
| 2024-10-31 | $5.5M |
| 2024-07-31 | $5.6M |
| 2024-04-30 | $5.1M |
| 2024-01-31 | $5.0M |